HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Closing fistulas in Crohn's disease--should the accent be on maintenance or safety?

AuthorsClaudio Fiocchi
JournalThe New England journal of medicine (N Engl J Med) Vol. 350 Issue 9 Pg. 934-6 (Feb 26 2004) ISSN: 1533-4406 [Electronic] United States
PMID14985492 (Publication Type: Comment, Editorial)
Chemical References
  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
Topics
  • Antibodies, Monoclonal (adverse effects, immunology, therapeutic use)
  • Crohn Disease (complications, drug therapy)
  • Drug Resistance
  • Drug Tolerance
  • Gastrointestinal Agents (adverse effects, immunology, therapeutic use)
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Infliximab
  • Intestinal Fistula (drug therapy, etiology)
  • Recurrence
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: